FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: FKRP mutations are associated with a large spectrum of dystroglycanopathies from severe forms, such as congenital muscular dystrophy and Walker–Warburg syndrome, to limb girdle muscular dystrophy type 2I (LGMD2I) [13–15].